Les Meilleures Cliniques et Coûts des traitements de sclérose en plaques en Lituanie 2026

Lithuania's leading centers for multiple sclerosis treatment include Vilnius University Hospital Santaros Klinikos and Kaunas Clinics. These academic institutions manage the national MS registry. Leading private options like Meliva Kardiolita Hospital and Medical Diagnostic and Treatment Center provide rapid diagnostics and specialized rehabilitation services.

• Santaros Klinikos: Primary hub offering autologous hematopoietic stem cell transplantation (HSCT) and advanced diagnostics.
• Kaunas Clinics: Major academic center providing specialized neurological care and involvement in research.
• Kardiolita Hospital: JCI-accredited facility in Vilnius serving 298,000 patients annually with 500+ doctors.
• Diagnostic Center: Accredited by Temos and JCI, focusing on high-quality rehabilitation and accuracy.

Bookimed Expert Insight: While public university hospitals hold the national registry, private centers in Vilnius offer a significant speed advantage. Medical Diagnostic and Treatment Center reports that 10% of their 48,000 annual patients arrive from abroad. This high international volume suggests these facilities have streamlined logistics for non-residents that public centers may lack.

Patient Consensus: Patients note that Santaros Klinikos is the main provider for complex therapies but advise preparing for wait times of several months. Many recommend using private clinics for faster MRI scans and initial neurology consultations to avoid delays in starting treatment.

Lithuania provides a comprehensive range of disease-modifying therapies (DMTs) for multiple sclerosis, including first-line injectables and high-efficacy infusions. Treatment spans platform therapies like Interferon beta-1a to advanced options such as Ocrelizumab. National health regulations and European Union standards govern availability within JCI-accredited facilities.

• Platform therapies: Includes Interferon beta-1a, Interferon beta-1b, Glatiramer acetate, Teriflunomide, and Dimethyl fumarate.
• High-efficacy orals: Cladribine, Fingolimod, Ponesimod, and Siponimod are available for active secondary progressive cases.
• Infusion treatments: Ocrelizumab, Ofatumumab, Natalizumab, and Alemtuzumab are used for highly active relapsing-remitting MS.
• Advanced procedures: Stem cell transplantation (AHSCT) and plasmapheresis are available for non-responsive, aggressive cases.

Bookimed Expert Insight: While Lithuania offers the same MS drug catalog as Western Europe, the clinical pathway is strictly tiered. Private centers like Meliva Kardiolita Hospital or the Medical Diagnostic and Treatment Center serve over 350,000 patients combined yearly. These high-volume centers prioritize rapid diagnostic staging, which is essential because high-efficacy DMTs usually require an EDSS score below 6.0 for approval.

Patient Consensus: Patients note that while the latest drugs are technically available, the approval process through the national health fund often requires documented proof of relapses. Many recommend preparing detailed medical records early to avoid delays when switching from platform therapies to high-efficacy infusions.

Lithuania fully reimburses Multiple Sclerosis (MS) prescription medications included in its List A registry. The Compulsory Health Insurance Fund covers 100% of the base price for insured residents. Patients may only pay a small premium if they choose higher-priced brand names over generics.

• Coverage level: State funds pay 100% of the medication base price for all insured persons.
• Financial cap: Annual out-of-pocket premiums are capped at approximately €49 for the cheapest versions.
• Eligibility criteria: Reimbursement requires a specialist neurologist prescription and specific diagnostic criteria for MS.
• Rehabilitation benefits: Insured patients qualify for up to 20 days of inpatient rehabilitation services annually.

Bookimed Expert Insight: Data from major Vilnius centers like Meliva Kardiolita Hospital and Medical Diagnostic and Treatment Center show a heavy focus on diagnostics. While the state covers many drugs, the approval process for modern monoclonal antibodies often requires documented failure of older therapies. Choosing a facility with over 200 specialists can help expedite the complex documentation needed for these high-tier reimbursement appeals.

Patient Consensus: Patients note that while basic drugs are easily accessed, switching to newer treatments can involve long paperwork delays. Many emphasize that keeping detailed records of MRI changes and relapses is vital for getting state approval for advanced biologics.

Private medical insurance is highly recommended for multiple sclerosis care in Lithuania to bypass public health wait times. While the national system covers basic treatments, neurologist shortages can delay appointments by 3 to 6 months. Private coverage ensures diagnostic access, like MRI scans, within 1 week instead of months.

• Specialist access: Private insurance reduces wait times for neurologists from months to just days.
• Diagnostic speed: Patients obtain critical MRI scans within 1 week for monitoring disease progression.
• Treatment flexibility: Insurance allows for second titles from specialists without requiring standard government referrals.
• Rehabilitation services: Plans often include enhanced coverage for vital physiotherapy and occupational therapy sessions.

Bookimed Expert Insight: Clinical data shows a major capacity gap between public and private sectors in Vilnius. Meliva Kardiolita Hospital treats 298,000 patients annually and maintains 33 specialized departments. This high volume suggests that private facilities are better equipped to handle complex diagnostic needs quickly. For chronic conditions like multiple sclerosis, choosing a clinic with high patient turnover ensures access to experienced specialists and modern infrastructure.

Patient Consensus: Patients emphasize that while the public system provides basic medications, the bureaucracy and long queues make private insurance essential. Many suggest securing an add-on policy early to ensure quick access during sudden flares or relapses.

Specialized neurological rehabilitation for multiple sclerosis is accessible in Lithuania through JCI-accredited hospitals and dedicated centers. Facilities offer multidisciplinary care including kinesiotherapy, hydrotherapy, and plasmapheresis. Treatment centers in Vilnius and Kaunas combine pharmacological management with physical medicine to improve patient mobility and cognitive function.

• Available modalities: Programs include kinesiotherapy, vertical baths, and specialized manual massages for spasticity.
• Advanced therapies: Clinics provide plasmapheresis and drug-based immunotherapy like Ocrevus (ocrelizumab) for progression.
• Hospital standards: Top facilities like Meliva Kardiolita Hospital hold JCI accreditation for patient safety.
• Diagnostic focus: Centers like Medical Diagnostic and Treatment Center emphasize high-quality recovery via precise diagnostics.

Bookimed Expert Insight: While public systems have longer waitlists, Lithuania's private sector is specifically designed for high-speed access. Meliva Kardiolita Hospital serves 298,000 patients annually and maintains 33 specialized departments. This scale allows international patients to bypass the typical 6-month wait times found in regional public neuro-rehab programs. Choosing a private center in Vilnius often ensures immediate access to both neurologists and intensive daily rehabilitation sessions.

Patient Consensus: Patients note that while basic physiotherapy is standard, private facilities offer better access to supplemental care like cognitive behavioral therapy. Some individuals navigate waitlists by utilizing private centers that specialize in fast-track recovery plans for international visitors.

Recognised Multiple Sclerosis specialists in Lithuania are primarily neurologists and neuroimmunologists practicing at major university centers. Patients can access care through the public system at Vilnius University Hospital or private facilities like Meliva Kardiolita Hospital and Medical Diagnostic and Treatment Center. A GP referral is required for public consultations.

• Public referral center: Vilnius University Hospital Neurology Department manages complex MS cases.
• Private facility: Meliva Kardiolita Hospital in Vilnius treats over 290,000 adult patients annually.
• Accredited diagnostics: Medical Diagnostic and Treatment Center holds JCI and Temos International accreditations.
• Clinical specialties: Experts provide Plasmapheresis, Ocrevus therapy, and specialized neuro-rehabilitation programs.

Bookimed Expert Insight: While private centers like Meliva Kardiolita or Medical Diagnostic and Treatment Center offer faster diagnostic sessions, the Lithuanian public system centralizes most high-cost disease-modifying therapies. Patients often use private clinics for rapid initial MRI scans and second opinions before transitioning to university hospitals for long-term pharmaceutical management. This hybrid approach reduces waiting times during the critical early diagnosis phase.

Patient Consensus: Patients note that finding a neurologist specifically focused on neuroimmunology is vital since general neurology training varies. Many suggest connecting with local MS organizations for informal specialist recommendations and travel to Poland if seeking additional treatment options.

Private facilities in Lithuania provide high-resolution 3 Tesla MRI scans crucial for detecting multiple sclerosis lesions. Leading centers like Medical Diagnostic and Treatment Center and Meliva Kardiolita Hospital offer rapid access to neuroimaging. These JCI-accredited institutions ensure diagnostic accuracy using advanced Siemens and GE technology.

• Diagnostic speed: Patients often secure 3 Tesla MRI appointments within 2 days.
• Clinical accreditation: Facilities hold Joint Commission International and Temos International quality certifications.
• Specialized infrastructure: Medical Diagnostic and Treatment Center operates 53 specialized medical departments.
• High-volume care: Meliva Kardiolita Hospital treats 298,000 patients annually with 510 doctors.

Bookimed Expert Insight: A major advantage in Lithuania is the concentration of multi-specialty expertise in Vilnius. Medical Diagnostic and Treatment Center integrates 53 departments under one roof. This allows for immediate neurological consultation following an MRI. This efficiency is rare compared to smaller diagnostic-only clinics. It significantly reduces the time from initial scan to a confirmed treatment plan.

Patient Consensus: Patients note that private clinics like Kardiolita are the top choice for avoiding long public waitlists. They emphasize that while some smaller centers have minor language barriers, the large hospital chains provide seamless multilingual support.